Nov 18, 2025 10:15
TMDX - TransMedics Group, Inc. Common Stock
| Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
|---|---|---|---|---|---|---|---|
| 123.62 7.86 (6.36%) | 0.15 (0.11%) | -0.41 (-0.31%) | -1.69 (-1.27%) | 0.38 (0.31%) | 8.09 (6.56%) | 1.05 (0.86%) | 1.87 (1.53%) |
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
Earnings & Ratios
- Basic EPS:
- 1.03
- Diluted EPS:
- 0.92
- Basic P/E:
- 127.6505
- Diluted P/E:
- 142.913
- RSI(14) 1m:
- 35.64
- VWAP:
- 131.41
- RVol:
Events
| Period | Kind | Movement | Occurred At |
|---|
Related News
Nov 13, 2025 13:15
Oct 08, 2025 13:37
Aug 27, 2025 18:16
Aug 04, 2025 16:30
Jul 31, 2025 17:16
Jul 31, 2025 09:16
Jul 30, 2025 21:06
Jul 03, 2025 22:32
Jun 28, 2025 13:10